Literature DB >> 8968851

Weight-loss with low or high carbohydrate diet?

A Golay1, C Eigenheer, Y Morel, P Kujawski, T Lehmann, N de Tonnac.   

Abstract

OBJECTIVE: With obesity being recognized as an important cardiovascular risk factor, it is important to determine the optimal hypocaloric diet for decreasing that risk. The goal of this study was to compare the effects of two hypocaloric diets of similar caloric value, but differing in carbohydrate content (25% and 45%).
SUBJECTS: Sixty-eight out-patients were followed for 12 w.
DESIGN: The patients were assigned to one of two groups that received either a low (25% CHO, n = 31) or a high (45% CHO, n = 37) carbohydrate hypocaloric diet (5.0 MJ/d, 1200 Kcal/d).
RESULTS: After 12 w, the mean weight loss was similar and did not differ significantly between the two groups: 10.2 +/- 0.7 kg (25% CHO) and 8.6 +/- 0.8 kg (45% CHO). Furthermore, loss of adipose tissue was similar, 8.1 +/- 0.5 kg (25% CHO) and 7.1 +/- 0.7 kg (45% CHO). Despite a high protein intake (1.4 g/kg/ideal body weight) there was loss of lean body mass: 2.2 +/- 0.4 kg (25% CHO) and 1.4 +/- 0.3 kg (45% CHO). The waist/hip ratio diminished significantly (P < 0.001) and identically in both groups. The fasting blood glucose (even though normal, along with cholesterol and triglyceride concentrations, were significantly decreased after weight loss. The fasting blood insulin which was mildly elevated before weight loss decreased more markedly with the 25% CHO diet compared to the 45% CHO diet (P < 0.003). The glucose/insulin ratio improved significantly (P < 0.05) after weight loss with both diets (0.17 +/- 0.04 mmol/mU (25% CHO) vs 0.10 +/- 0.03 mmol/mU (45% CHO).
CONCLUSIONS: Neither diet offered a significant advantage when comparing weight loss or other, metabolic parameters over a 12 w period. However, considering the greater improvement of fasting blood insulin, the glucose/insulin ratio and blood triglyceride, the low carbohydrate diet (25%) could be more favourable in the long-term. The improvement of fasting blood insulin could be explained by the differences in monounsaturated fat composition in the low carbohydrate diet.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968851

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  7 in total

1.  Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets.

Authors:  N Viguerie; H Vidal; P Arner; C Holst; C Verdich; S Avizou; A Astrup; W H M Saris; I A Macdonald; E Klimcakova; K Clément; A Martinez; J Hoffstedt; T I A Sørensen; D Langin
Journal:  Diabetologia       Date:  2004-12-29       Impact factor: 10.122

2.  A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study.

Authors:  Valentina Volynets; Jürgen Machann; Markus A Küper; Ina B Maier; Astrid Spruss; Alfred Königsrainer; Stephan C Bischoff; Ina Bergheim
Journal:  Eur J Nutr       Date:  2012-04-28       Impact factor: 5.614

Review 3.  Diet in the management of weight loss.

Authors:  Irene Strychar
Journal:  CMAJ       Date:  2006-01-03       Impact factor: 8.262

4.  When is a high fat diet not a high fat diet?

Authors:  Richard D Feinman
Journal:  Nutr Metab (Lond)       Date:  2005-10-17       Impact factor: 4.169

5.  Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction.

Authors:  Jeff S Volek; Richard D Feinman
Journal:  Nutr Metab (Lond)       Date:  2005-11-16       Impact factor: 4.169

6.  Thermodynamics of weight loss diets.

Authors:  Eugene J Fine; Richard D Feinman
Journal:  Nutr Metab (Lond)       Date:  2004-12-08       Impact factor: 4.169

7.  Dietary Intake and Its Relationship to Different Body Mass Index Categories: A Population-Based Study.

Authors:  Ali Asghar Rashidi; Ali Reza Heidari Bakavoli; Amir Avan; Malihe Aghasizade; Hamideh Ghazizadeh; Maryam Tayefi; Sayyed Saeid Khayyatzadeh; Mahmoud Ebrahimi; Mohsen Moohebati; Mohammad Safarian; Mohsen Nematy; Mostafa Sadr-Bazzaz; Gordon A Ferns; Majid Ghayour Mobarhan
Journal:  J Res Health Sci       Date:  2018-09-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.